These novel medications , Retatrutide, represent a remarkable advancement in addressing obesity and possibly associated ailments . They all are classified as GLP-1 receptor stimulators, indicating they to replicate the body's GLP-1 peptide, boosting glucose production and suppressing hunger . While Semaglutide each one works somewhat similarly, the